000			01617 a2200445 4500
005			20250516044239.0
264		0	_c20111228
008			201112s 0 0 eng d
022			_a1872-9096
024	7		_a10.1016/j.antiviral.2011.06.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmith, Miles C
245	0	0	_aCK2 inhibitors increase the sensitivity of HSV-1 to interferon-β. _h[electronic resource]
260			_bAntiviral research _cSep 2011
300			_a259-66 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdenoviridae _xdrug effects
650	0	4	_aAntiviral Agents _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCasein Kinase II _xantagonists & inhibitors
650	0	4	_aCell Line
650	0	4	_aHerpes Simplex _xdrug therapy
650	0	4	_aHerpesvirus 1, Human _xdrug effects
650	0	4	_aHost-Pathogen Interactions
650	0	4	_aHumans
650	0	4	_aImmediate-Early Proteins _xgenetics
650	0	4	_aInterferon-beta _xpharmacology
650	0	4	_aLung _xcytology
650	0	4	_aMicroscopy, Fluorescence
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aSignal Transduction
650	0	4	_aUbiquitin-Protein Ligases _xgenetics
650	0	4	_aVesiculovirus _xdrug effects
650	0	4	_aVirus Replication _xdrug effects
700	1		_aBayless, Adam M
700	1		_aGoddard, Erica T
700	1		_aDavido, David J
773	0		_tAntiviral research _gvol. 91 _gno. 3 _gp. 259-66
856	4	0	_uhttps://doi.org/10.1016/j.antiviral.2011.06.009 _zAvailable from publisher's website
999			_c20975516 _d20975516